GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Amarin Corporation Plc (AMRN) [hlAlert]

Rating:
Hold AMRN

Amarin Corporation Plc (AMRN) rated Hold with price target $8.50 by Chardan Capital Markets

Posted on: Wednesday,  Mar 20, 2013  8:25 AM ET by Chardan Capital Markets

Amarin Corporation Plc (NASDAQ: AMRN)
rated Hold with price target $8.50 by Chardan Capital Markets.

Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical company with a focus on cardiovascular disease. Amarin has a range of clinical and preclinical stage compounds to treat central nervous system (CNS) disorders, including Huntington?s disease, myasthenia gravis and Parkinson?s disease. Its cardiovascular programs and non-core CNS programs include AMR101, EN101, Sublingual Apomorphine and AMR 103. The Company's subsidiaries include Amarin Neuroscience Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharma Inc, Amarin Finance Limited and Ester Neurosciences Limited.

Chardan Capital Markets
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/20/2013 8:25 AM Hold
None
7.94 8.50
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy